Today's top #BusinessModel report is on Life Sciences rebrand.ly/jbyxvj2 Get our free reports on geography of your interest to your mailbox regularly https://rb.gy/cx2upn

1. TRACXN TOP BUSINESS MODELS REPORT
April 11, 2022
LIFE SCIENCES

2. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Contents
Life Sciences Funding Overview 3
Top Funded Business Models 4
One Pagers 9
Appendix 59
2

3. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Funding in last 1 year
3
Oncology $15.0B
Genomics $13.9B
Life Sciences Platforms and Tools $9.8B
Life Sciences Tech $8.7B
Neurology $4.9B
Immunology $4.2B
Y-o-Y Funding
Top Investors by Funding Rounds
Seed
Stage
Y Combinator
SOSV
Khosla Ventures
35
9
5
Early
Stage
Alexandria
Casdin Capital
Orbimed
35
31
28
Late
Stage
RA Capital Management
Fidelity Investments
Sequoia Capital
12
10
10
Funding by Geography
Top Feeds by $ Funding
Top Funding Rounds
United States (65%)
China (9%)
United Kingdom (7%)
France (2%)
Switzerland (2%)
Germany (2%)
Canada (2%)
Others (10%)
$ Funding # Rounds
Caris Life Sciences
(1996, United States)
$830M - Series D
AboGen
(2012, United States)
$700M - Series A
CMR Surgical
(2014, United Kingdom)
$600M - Series D
Eikon
(2019, United States)
$518M - Series B
Neumora
(2020, United States)
$500M - Series A
Laronde
(2017, United States)
$440M - Series B
Pivot Bio
(2010, United States)
$430M - Series D
XtalPi
(2014, United States)
$400M - Series D
Adagio
(2020, United States)
$336M - Series C
Sotio
(2010, Czech Republic)
$317M - Series D
Medable
(2012, United States)
$304M - Series D
Freenome
(2014, United States)
$300M - Series D

4. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (1/5)
4
Rank Business Model $ Funding # Rounds Top Funding Round Details
1<> 0 Drugs for Multiple Cancer Types $8.2B 256 Sotio | $317M | Series D Link
2<> 0 Life Sciences Research Services $3.3B 102 Immunai | $215M | Series B Link
3<> 0 Gene Therapy Drugs $1.6B 47 Wugen | $172M | Series B Link
4▲12 Sequencing-based Genomic Precision Medicine $1.6B 35 Caris Life Sc.. | $830M | Series D Link
5<> 0 Neurological Disorder Drugs $1.6B 40 Neumora | $500M | Series A Link
6▲17 Robot Assisted Surgery $1.4B 24 CMR Surgical | $600M | Series D Link
7▲11 Neurodegenerative Disorders Drugs $1.3B 36 Sonoma Biothe.. | $265M | Series B Link
8▼4 Cheminformatics Software $1.3B 28 XtalPi | $400M | Series D Link
9▼3 Cancer Diagnostic Tests $1.1B 12 Freenome | $300M | Series D Link
10▲1 Genomic Data Analysis Platforms $1.0B 17 Insilico | $255M | Series C Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

5. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (2/5)
5
Rank Business Model $ Funding # Rounds Top Funding Round Details
11▼7 Pan-Cancer Drugs $794M 21 Hummingbird B.. | $125M | Series C Link
12▲152 Biopreservation Devices $775M 4 AboGen | $700M | Series A Link
13▲26 Synthetic Biology $735M 12 Pivot Bio | $430M | Series D Link
14▲21 Genomic Sequencing Instruments $731M 11 Element Biosc.. | $276M | Series C Link
15▼9 Gene Editing Platforms $700M 17 Prime Medicine | $200M | Series B Link
16▲37 Proteomics Drug Discovery Software $691M 13 Eikon | $518M | Series B Link
17▼5 Diversified $688M 20 CinCor | $143M | Series B Link
18▼2 Inflammatory Diseases Drugs $642M 17 Apollo Therap.. | $145M | Series A Link
19▲6 Diabetes Drugs $553M 17 Jaguar Gene T.. | $139M | Series B Link
20▲12 Nucleic Acid Sequencing Equipment $490M 11 Nanopore | $271M | Series H Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

6. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (3/5)
6
Rank Business Model $ Funding # Rounds Top Funding Round Details
21▲77 Nucleic Acid Synthesis Instruments $476M 7 DNA Script | $200M | Series C Link
22▲191 Cancer Precision Medicine Diagnostic Tests $462M 16 ITM | $109M | Series D Link
23▲11 Clinical Trial Patient Recruitment Platforms $442M 9 Reify Health | $220M | Series C Link
24▼15 Retinal Disorders Drugs $433M 17 Vedere | $77.0M | Series A Link
25▲15 Genomics Research Services $423M 24 Kallyope | $236M | Series D Link
26▲61 Decentralized Clinical Trial Management $418M 4 Medable | $304M | Series D Link
27▲73 Radioisotopes for Imaging $411M 9 SHINE Medical.. | $150M | Series C Link
28▼24 DNA Liquid Biopsy Diagnostics $407M 10 Jiyinga Techn.. | $116M | Series C Link
29▼10 COVID-19 Drugs $404M 8 Adagio | $336M | Series C Link
30▼20 RNA Interference Platforms $367M 5 Siwei Biotech.. | $188M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

7. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (4/5)
7
Rank Business Model $ Funding # Rounds Top Funding Round Details
31▲3 Gene Delivery Platforms $360M 9 Synthego | $200M | Series E Link
32▼13 Drug Resistant Infections $343M 14 Vedanta Bios.. | $68.0M | Series D Link
33▲117 Chemoproteomics Software $341M 7 Seismic | $101M | Series A Link
34▲83 Life Science R&D Workflow Management Software $335M 7 Benchling | $200M | Series E Link
35▲237 Intravenous Drug Delivery Systems $323M 5 Enable Inject.. | $215M | Series C Link
36▲80 Proteomic Research Reagents and KIts $313M 20 ABclonal Biot.. | $188M | Series D Link
37▲113 Cardiac Diagnostic Devices $304M 14 Imperative Care | $260M | Series D Link
38▼24 Agrigenomics $300M 13 Inari | $208M | Series D Link
39▲45 Renal Disorders Drugs $300M 9 Ceptur Thera.. | $75.0M | Series A Link
40▲38 Ultrasound Imaging Devices $300M 6 Exo | $220M | Series C Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

8. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (5/5)
8
Rank Business Model $ Funding # Rounds Top Funding Round Details
41▲30 Wound Healing Drugs $299M 9 Endeavor Biom.. | $101M | Series B Link
42▲7 Genome Sequence Analysis Software $285M 8 DNAnexus | $200M | Series H Link
43▲167 Healthcare Data Analysis for Drug Discovery $277M 6 Verana Health | $150M | Series E Link
44▼26 At-Home Preventive Genetic Test Kits $274M 8 Variant Bio | $105M | Series B Link
45▲235 Hemodialyzers $269M 2 Quanta | $245M | Series D Link
46-- Life Sciences Research Instruments $265M 8 Esco Lifescie.. | $200M | Series A Link
47▲73 Aesthetic Medicines $259M 5 Dermavant | $160M | Series D Link
48▼5 Congestive Heart Failure Treatment Devices $256M 15 Ancora Heart | $80.0M | Series D Link
49▲3 Lung Infection Drugs $252M 6 HilleVax | $135M | Series D Link
50▲8 Drug Development Immunoassays $251M 11 Virtue Diagno.. | $100M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

9. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sotio (2010, Czech Republic)
$317M - Series D - Dec 2021
Exscientia (2012, United Kingdom)
$225M - Series D - Apr 2021
Umoja Biopharma (2019, United States)
$210M - Series B - Jun 2021
Affini-T Ther.. (2020, United States)
$175M - Series D - Mar 2022
NMS Group (1965, Italy)
$158M - PE - Jan 2022
Shoreline Bio.. (2020, United States)
$140M - Series B - Nov 2021
Nuvalent (2017, United States)
$135M - Series B - May 2021
View all 256 Funding Rounds on Tracxn Platform
Drugs for Multiple Cancer Types
01
9
Back to index
Oncology (Guardant Health)
(# Cos: 4615 | $104B)
Drugs (Exscientia)
(# Cos: 2980 | $79.4B)
Diversified (Moderna)
(# Cos: 2386 | $64.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$8.2B (▼33.8%)
256(▼13.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
197
$64.0B
1704
386
2386
278
Moderna
(2010, United States, $2.8B)
Exscientia
(2012, United Kingdom, $429M)
Kite Pharma
(2009, United States, $97.7M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

10. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Immunai (2018, United States)
$215M - Series B - Oct 2021
Arbor Biotech.. (2016, United States)
$215M - Series B - Nov 2021
Synthego (2012, United States)
$200M - Series E - Feb 2022
LifeMine Ther.. (2016, United States)
$175M - Series C - Mar 2022
Wugen (2018, United States)
$172M - Series B - Jul 2021
Mammoth (2017, United States)
$150M - Series D - Sep 2021
Dewpoint Ther.. (2018, United States)
$150M - Series C - Feb 2022
View all 102 Funding Rounds on Tracxn Platform
Life Sciences Research Services
02
10
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9834 | $52.5B)
Research Services (Ancestry)
(# Cos: 4984 | $30.2B)
Diversified (Ginkgo Bioworks)
(# Cos: 3341 | $23.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$3.3B (▲15.4%)
102(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
317
$23.6B
1820
181
3341
153
Ginkgo Bioworks
(2009, United States, $796M)
Human Longevity
(2013, United States, $330M)
Amyris
(2003, United States, $487M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

11. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Therapy Drugs
03
11
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.6B (▼40.9%)
47(▼37.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
59
$13.2B
402
81
592
77
Genomics (23andMe)
(# Cos: 7760 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4220 | $52.8B)
Clinical Genomics (Guardant Health)
(# Cos: 2273 | $41.3B)
Therapeutics (Alnylam)
(# Cos: 592 | $13.2B)
Alnylam
(2002, United States, $17.0M)
Spark Therapeutics
(2013, United States, $82.8M)
AskBio
(2001, United States, $235M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Wugen (2018, United States)
$172M - Series B - Jul 2021
Forge Biologics (2020, United States)
$120M - Series B - Apr 2021
Ring Therapeu.. (2018, United States)
$117M - Series B - Jul 2021
Sirnaomics (2007, United States)
$105M - Series E - Jul 2021
Dyno Therapeu.. (2018, United States)
$100M - Series A - May 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
Turnstone Biologics (2015, Canada)
$80.0M - Series D - Jul 2021
View all 47 Funding Rounds on Tracxn Platform

12. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sequencing-based Genomic Precision
Medicine
04
12
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.6B (▲119%)
35(▲9.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
37
$12.5B
234
50
424
34
Genomics (23andMe)
(# Cos: 7760 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4220 | $52.8B)
Clinical Genomics (Invitae)
(# Cos: 2273 | $41.3B)
Diagnostics (Adaptive Biotechnologies)
(# Cos: 1643 | $27.5B)
Sequencing-based (Guardant Health)
(# Cos: 1340 | $25.5B)
Precision Medicine (Bluebird Bio)
(# Cos: 424 | $12.5B)
Bluebird Bio
(1992, United States, $136M)
UniQure
(1998, Netherlands, $200M)
Caris Life Sciences
(1996, United States, $830M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Caris Life Sc.. (1996, United States)
$830M - Series D - May 2021
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
SHINE Medical.. (2010, United States)
$150M - Series C - Jun 2021
BerryOncology (2017, China)
$108M - Series B - Aug 2021
Celsius Thera.. (2018, United States)
$83.0M - Series B - Mar 2022
Sherlock Bios.. (2018, United States)
$80.0M - Series B - Mar 2022
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
View all 35 Funding Rounds on Tracxn Platform

13. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Neumora (2020, United States)
$500M - Series A - Oct 2021
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
Septerna (2020, United States)
$100M - Series A - Jan 2022
Vigil (2020, United States)
$90.0M - Series B - Aug 2021
Flare Therape.. (2021, United States)
$82.0M - Series A - May 2021
Beckley Psyt.. (1998, United Kingdom)
$80.0M - Series B - Aug 2021
Ceptur Therap.. (2021, United States)
$75.0M - Series A - Jan 2022
View all 40 Funding Rounds on Tracxn Platform
Neurological Disorder Drugs
05
13
Back to index
Neurology (AskBio)
(# Cos: 2633 | $32.0B)
Drugs (Biogen)
(# Cos: 1407 | $24.8B)
Diversified (Jazz Pharmaceuticals)
(# Cos: 352 | $7.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.6B (▲9.1%)
40(▼25.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
33
$7.3B
251
59
352
40
Jazz Pharmaceuticals
(2003, Ireland, $265M)
PureTech Health
(2001, United States, $107M)
Biohaven Pharmaceutical
(2014, United States, $84.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

14. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Robot Assisted Surgery
06
14
Back to index
Surgical Instruments (Augmedics)
(# Cos: 705 | $7.0B)
Robotic Surgery (Intuitive)
(# Cos: 186 | $4.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.4B (▲182%)
24(▲26.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
20
$4.6B
116
13
186
26
Intuitive
(1995, United States, $47.0M)
Corindus Vascular Robo..
(2001, United States, $21.9M)
CMR Surgical
(2014, United Kingdom, $1.0B)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
CMR Surgical (2014, United Kingdom)
$600M - Series D - Jun 2021
Edge Medical Robotics (2017, China)
$200M - Series C - Nov 2021
Memic Surgery (2013, Israel)
$96.0M - Series D - Apr 2021
Distalmotion (2012, Switzerland)
$90.0M - Series E - Jan 2022
PROCEPT BioRo.. (2009, United States)
$85.0M - Series G - Jun 2021
ColubrisMX (2017, United States)
$76.1M - Series C - Jun 2021
$69.0M - Series B - May 2021
View all 24 Funding Rounds on Tracxn Platform

15. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
Amylyx Pharma.. (2013, United States)
$135M - Series C - Jul 2021
Skyhawk Thera.. (2017, United States)
$133M - Series B - Sep 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
LEXEO Therape.. (2018, United States)
$100M - Series B - Sep 2021
Verge Genomics (2015, United States)
$98.0M - Series B - Dec 2021
Vanqua Bio (2019, United States)
$85.0M - Series B - Sep 2021
View all 36 Funding Rounds on Tracxn Platform
Neurodegenerative Disorders Drugs
07
15
Back to index
Neurology (MindMaze)
(# Cos: 2633 | $32.0B)
Drugs (AskBio)
(# Cos: 1407 | $24.8B)
Neurodegenerative (Biogen)
(# Cos: 515 | $9.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.3B (▲107%)
36(▼14.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
32
$9.1B
355
60
515
48
Biogen
(1978, United States, $80.0M)
AskBio
(2001, United States, $235M)
Amylyx Pharmaceuticals
(2013, United States, $172M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

16. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cheminformatics Software
08
16
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.3B (▼39.3%)
28(▼12.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
22
$5.1B
152
7
309
26
Life Sciences Tech (Illumina)
(# Cos: 5001 | $28.0B)
Research & Development (Medidata)
(# Cos: 4017 | $23.3B)
Drug Discovery (ATAI)
(# Cos: 1205 | $12.5B)
Cheminformatics (Exscientia)
(# Cos: 309 | $5.1B)
Exscientia
(2012, United Kingdom, $429M)
ATAI
(2018, Germany, $387M)
Schrodinger
(1990, United States, $162M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
XtalPi (2014, United States)
$400M - Series D - Aug 2021
Exscientia (2012, United Kingdom)
$225M - Series D - Apr 2021
InterVenn (2017, United States)
$201M - Series C - Aug 2021
Owkin (2016, France)
$180M - Series B - Nov 2021
METiS (2021, United States)
$150M - Series B - Apr 2022
$86.0M - Series A - Dec 2021
HotSpot Thera.. (2017, United States)
$100M - Series C - Nov 2021
View all 28 Funding Rounds on Tracxn Platform

17. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Freenome (2014, United States)
$290M - Series D - Jan 2022
$300M - Series D - Dec 2021
PathAI (2016, United States)
$165M - Series C - May 2021
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Color (2013, United States)
$100M - Series E - Nov 2021
Sherlock Bios.. (2018, United States)
$80.0M - Series B - Mar 2022
Craif (2018, Japan)
$11.3M - Series B - Nov 2021
View all 12 Funding Rounds on Tracxn Platform
Cancer Diagnostic Tests
09
17
Back to index
Oncology (Moderna)
(# Cos: 4615 | $104B)
In-Vitro Diagnostic Tests (Guardant Health)
(# Cos: 1159 | $19.1B)
Pan Cancer (GRAIL)
(# Cos: 195 | $6.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B (▼15.3%)
12(▼36.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
23
$6.2B
125
9
195
16
GRAIL
(2016, United States, $2.0B)
PathAI
(2016, United States, $255M)
Color
(2013, United States, $491M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

18. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Insilico (2014, China)
$255M - Series C - Jun 2021
Benchling (2012, United States)
$100M - Series F - Nov 2021
$200M - Series E - Apr 2021
iCarbonX (2015, China)
$151M - Series D - Apr 2021
BostonGene (2015, United States)
$150M - Series B - Apr 2022
Recludix Pharma (2020, United States)
$60.0M - Series A - Nov 2021
Helix (2015, United States)
$50.0M - Series C - Jun 2021
View all 17 Funding Rounds on Tracxn Platform
Genomic Data Analysis Platforms
10
18
Back to index
Genomics (MyHeritage)
(# Cos: 7760 | $82.8B)
Genome Informatics (Human Longevity)
(# Cos: 769 | $5.6B)
Integrative Bioinformatics Platforms
(Benchling)
(# Cos: 504 | $4.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.0B (▼1.2%)
17(▼22.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
43
$4.5B
177
6
504
20
Benchling
(2012, United States, $412M)
Human Longevity
(2013, United States, $330M)
Schrodinger
(1990, United States, $162M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

19. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Hummingbird Biosc.. (2015, Singapore)
$125M - Series C - May 2021
Anaveon (2017, Switzerland)
$119M - Series B - Dec 2021
Obsidian Ther.. (2015, United States)
$115M - Series B - Sep 2021
Boundless Bio (2018, United States)
$106M - Series B - Apr 2021
Elpiscience (2017, China)
$105M - Series C - May 2021
Hibercell (2015, United States)
$67.4M - Series B - May 2021
TCRCure Biopharma (2016, China)
$47.3M - Series B - Feb 2022
View all 21 Funding Rounds on Tracxn Platform
Pan-Cancer Drugs
11
19
Back to index
Oncology (Guardant Health)
(# Cos: 4615 | $104B)
Drugs (Moderna)
(# Cos: 2980 | $79.4B)
Pan Cancer (GigaGen)
(# Cos: 341 | $7.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$794M (▼43.1%)
21(▼52.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
26
$7.3B
223
44
341
37
GigaGen
(2011, United States, $36.1M)
TScan Therapeutics
(1995, United States, $180M)
Obsidian Therapeutics
(2015, United States, $165M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

20. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
AboGen (2012, United States)
$700M - Series A - Aug 2021
Bridge to Life (2012, United States)
$56.0M - Series A - Aug 2021
Genepoint Biological .. (2015, China)
Undisclosed - Series C - Jul 2021
$18.8M - Series C - Jun 2021
Biopreservation Devices
12
20
Back to index
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9834 | $52.5B)
Instruments (Illumina)
(# Cos: 2050 | $12.7B)
Preservation (Brooks Automation)
(# Cos: 80 | $911M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$775M (▲1225%)
4(▼50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
6
$911M
38
1
80
4
Brooks Automation
(1978, United States)
Stirling Ultracold
(2009, United States, $8.7M)
Atelerix
(2017, United Kingdom, $1.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

21. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Pivot Bio (2010, United States)
$430M - Series D - Jul 2021
LifeMine Ther.. (2016, United States)
$175M - Series C - Mar 2022
Antheia (2013, United States)
$73.0M - Series B - Jul 2021
Tavotek (2018, United States)
$35.0M - Series B - Nov 2021
OriCiro Genomics (2018, Japan)
$7.3M - Series B - Jul 2021
Cemvita Factory (2017, United States)
$5.0M - Series B - Mar 2022
Embion Technolo.. (2016, Switzerland)
$4.9M - Series A - Dec 2021
View all 12 Funding Rounds on Tracxn Platform
Synthetic Biology
13
21
Back to index
Genomics (23andMe)
(# Cos: 7760 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4220 | $52.8B)
Synthetic Biology (Ginkgo Bioworks)
(# Cos: 70 | $3.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$735M (▲165%)
12(▲9.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
9
$3.5B
54
3
70
13
Ginkgo Bioworks
(2009, United States, $796M)
Amyris
(2003, United States, $487M)
Bolt Threads
(2009, United States, $214M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

22. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomic Sequencing Instruments
14
22
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$731M (▲142%)
11(▼8.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
12
$2.8B
58
5
98
10
Genomics (MyHeritage)
(# Cos: 7760 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1695 | $17.2B)
Instrument Systems (10X Genomics)
(# Cos: 323 | $5.6B)
Nucleic Acid Analysis (PacBio)
(# Cos: 196 | $3.2B)
Sequencing (Nanopore)
(# Cos: 98 | $2.8B)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
Element Biosciences
(2017, United States, $401M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Element Biosc.. (2017, United States)
$276M - Series C - Jun 2021
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
GeneMind (2012, China)
$63.6M - Series B - Sep 2021
$38.7M - Series B - Jun 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
Jinshi Technology (2017, China)
$15.5M - Series B - Sep 2021
SimplSeq (2019, United States)
$2.0M - Seed - Apr 2021
View all 11 Funding Rounds on Tracxn Platform

23. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Editing Platforms
15
23
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$700M (▼44.1%)
17(▼26.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$2.7B
63
3
92
15
Genomics (MyHeritage)
(# Cos: 7760 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1695 | $17.2B)
Technology Platforms (Twist Bioscience)
(# Cos: 365 | $8.1B)
Gene Editing (eGenesis)
(# Cos: 92 | $2.7B)
eGenesis
(2015, United States, $265M)
Locus Biosciences
(2015, United States, $32.3M)
Scribe Therapeutics
(2018, United States, $120M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Prime Medicine (2019, United States)
$200M - Series B - Jul 2021
Korro Bio (2018, United States)
$116M - Series B - Jan 2022
SalioGen Ther.. (2019, United States)
$115M - Series B - Dec 2021
EdiGene (2015, China)
$61.5M - Series B - Apr 2021
CureGenetics (2016, China)
$60.0M - Series B - Jan 2022
Weiyuan Gene (2018, China)
$46.9M - Series D - Nov 2021
Zhengxu Biotechnology (2020, China)
$46.9M - Series C - Nov 2021
View all 17 Funding Rounds on Tracxn Platform

24. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Proteomics Drug Discovery Software
16
24
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$691M (▲239%)
13(▲62.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$1.8B
52
1
122
13
Life Sciences Tech (Illumina)
(# Cos: 5001 | $28.0B)
Research & Development (Medidata)
(# Cos: 4017 | $23.3B)
Drug Discovery (Exscientia)
(# Cos: 1205 | $12.5B)
Proteomics (Vividion Therapeutics)
(# Cos: 122 | $1.8B)
Vividion Therapeutics
(2016, United States, $271M)
Biognosys
(2008, Switzerland, $9.1M)
Seer
(2017, United States, $128M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Eikon (2019, United States)
$518M - Series B - Jan 2022
$148M - Series A - May 2021
Seismic (2019, United States)
$101M - Series A - Feb 2022
Interline The.. (2020, United States)
$92.0M - Series C - May 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
Avilar (2020, United States)
$60.0M - Seed - Nov 2021
Gandeeva (2017, Canada)
$40.0M - Series A - Jan 2022
View all 13 Funding Rounds on Tracxn Platform

25. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
CinCor (2018, United States)
$143M - Series B - Oct 2021
TransThera Sciences (2016, China)
$100M - Series D - Jul 2021
Cellino (2017, United States)
$80.0M - Series A - Jan 2022
Cardior Pharmaceuti.. (2016, Germany)
$75.2M - Series B - Aug 2021
Juventas Ther.. (2007, United States)
$64.2M - Series C - Oct 2021
TenSixteen (2020, United States)
$40.0M - Series A - Jan 2022
ARMGO Pharma (2004, United States)
$35.0M - Series B - Dec 2021
View all 20 Funding Rounds on Tracxn Platform
Diversified
17
25
Back to index
Cardiac and Vascular Disorders (Withings)
(# Cos: 2608 | $31.6B)
Drugs (Moderna)
(# Cos: 348 | $10.8B)
Diversified (Sarepta)
(# Cos: 267 | $6.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$688M (▼11.7%)
20(▲5.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
46
$6.4B
209
44
267
19
Sarepta
(1980, United States)
Esperion Therapeutics
(1998, United States, $130M)
Tenaya Therapeutics
(2016, United States, $248M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

26. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Apollo Thera.. (2007, United Kingdom)
$145M - Series A - Jun 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Septerna (2020, United States)
$100M - Series A - Jan 2022
Evommune (2020, United States)
$83.0M - Series A - Sep 2021
Aristea Thera.. (2018, United States)
$63.0M - Series B - Jul 2021
Sparrow Pharm.. (2013, United States)
$50.0M - Series A - May 2021
Mestag Thera.. (2020, United Kingdom)
$34.0M - Seed - Aug 2021
View all 17 Funding Rounds on Tracxn Platform
Inflammatory Diseases Drugs
18
26
Back to index
Immunology (Biogen)
(# Cos: 916 | $23.7B)
Drugs (Moderna)
(# Cos: 776 | $22.9B)
Inflammatory Diseases (Nimbus
Therapeutics)
(# Cos: 242 | $4.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$642M (▲5.4%)
17(▼29.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
22
$4.2B
175
24
242
28
Nimbus Therapeutics
(2009, United States, $242M)
RedHill Biopharma
(2009, Israel, $13.5M)
Gossamer Bio
(2017, United States, $330M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

27. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Diabetes Drugs
19
27
Back to index
Diabetes (Dexcom)
(# Cos: 905 | $9.3B)
Drugs (Ocugen)
(# Cos: 247 | $5.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$553M (▲44.9%)
17(▼34.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$5.2B
171
25
247
28
Ocugen
(2013, United States, $18.9M)
Pendulum
(2012, United States, $57.0M)
Xeris Pharma
(2005, United States, $155M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
$53.9M - Series D - Apr 2021
Kriya Therape.. (2012, United States)
$100M - Series B - Jul 2021
Cellino (2017, United States)
$80.0M - Series A - Jan 2022
Elevian (2017, United States)
$40.0M - Series A - Sep 2021
MingSight (2009, United States)
$20.0M - Series A - Nov 2021
View all 17 Funding Rounds on Tracxn Platform

28. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nucleic Acid Sequencing Equipment
20
28
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$490M (▲57.5%)
11(▲10%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$3.3B
68
7
93
11
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9834 | $52.5B)
Instruments (Zeiss)
(# Cos: 2050 | $12.7B)
Genomics (Nanopore)
(# Cos: 231 | $5.1B)
Nucleic Acid Sequencing (Illumina)
(# Cos: 93 | $3.3B)
Illumina
(1998, United States, $28.0M)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
GeneMind (2012, China)
$63.6M - Series B - Sep 2021
$38.7M - Series B - Jun 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
Depixus (2012, France)
$34.5M - Series A - Dec 2021
Jinshi Technology (2017, China)
$15.5M - Series B - Sep 2021
SimplSeq (2019, United States)
$2.0M - Seed - Apr 2021
View all 11 Funding Rounds on Tracxn Platform

29. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nucleic Acid Synthesis Instruments
21
29
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$476M (▲303%)
7(▲75%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$675M
14
1
28
4
Genomics (MyHeritage)
(# Cos: 7760 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1695 | $17.2B)
Instrument Systems (Nanopore)
(# Cos: 323 | $5.6B)
Nucleic Acid Synthesis (DNA
Script)
(# Cos: 28 | $675M)
DNA Script
(2014, France, $280M)
Molecular Assemblies
(2013, United States, $78.5M)
Nuclera Nucleics
(2013, United Kingdom, $54.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
DNA Script (2014, France)
$200M - Series C - Oct 2021
Nutcracker Th.. (2018, United States)
$167M - Series C - Mar 2022
Nuclera Nucl.. (2013, United Kingdom)
$42.5M - Series B - Feb 2022
Molecular Ass.. (2013, United States)
$25.8M - Series B - Mar 2022
$10.0M - Series A - Nov 2021
$24.0M - Series A - Apr 2021
Switchback Sy.. (2019, United States)
$7.0M - Series A - Oct 2021

30. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cancer Precision Medicine Diagnostic
Tests
22
30
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$462M (▲1376%)
16(▲77.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$840M
40
2
59
8
Oncology (Moderna)
(# Cos: 4615 | $104B)
In-Vitro Diagnostic Tests (Adaptive
Biotechnologies)
(# Cos: 1159 | $19.1B)
Diversified (Guardant Health)
(# Cos: 516 | $9.8B)
Precision Medicine (Personalis)
(# Cos: 59 | $840M)
Personalis
(2011, United States, $87.3M)
PierianDx
(2014, United States, $69.3M)
HalioDx
(2015, France, $31.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
ITM (2004, Germany)
$36.4M - Series D - Mar 2022
$28.0M - Series D - Feb 2022
$30.5M - Series D - Jun 2021
$109M - Series D - Apr 2021
Strata Oncology (2015, United States)
$90.0M - Series C - Jul 2021
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
PierianDx (2014, United States)
$30.0M - Series C - Nov 2021
View all 16 Funding Rounds on Tracxn Platform

31. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Clinical Trial Patient Recruitment
Platforms
23
31
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$442M (▲46.8%)
9(▼30.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
13
$1.2B
75
1
218
11
Life Sciences Tech (Exscientia)
(# Cos: 5001 | $28.0B)
Research & Development (Illumina)
(# Cos: 4017 | $23.3B)
Clinical Trials (Medidata)
(# Cos: 977 | $4.0B)
Scientific Sourcing (TrialSpark)
(# Cos: 254 | $1.4B)
Patients (Evidation)
(# Cos: 218 | $1.2B)
Evidation
(2012, United States, $259M)
TrialSpark
(2014, United States, $250M)
myTomorrows
(2012, Netherlands, $22.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Reify Health (2012, United States)
$220M - Series C - Aug 2021
TrialSpark (2014, United States)
$156M - Series C - Sep 2021
Antidote (2008, United Kingdom)
$23.2M - Series C - Jun 2021
TrialJectory (2017, United States)
$20.0M - Series A - Feb 2022
Mendel Health (2016, United States)
$18.0M - Series A - Jun 2021
BEKHealth (2016, United States)
$4.6M - Series A - Jun 2021
Infiuss (2018, United States)
$500K - Seed - Oct 2021
View all 9 Funding Rounds on Tracxn Platform

32. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Vedere (2019, United States)
$77.0M - Series A - May 2021
EyeBio (2021, United Kingdom)
$65.0M - Series A - Feb 2022
Neurophth (2016, China)
$63.0M - Series C - Nov 2021
LENZ Therapeu.. (2021, United States)
$47.0M - Series A - Jun 2021
Sydnexis (2014, United States)
$45.0M - Series B - Aug 2021
Phanes Therap.. (2016, United States)
$40.0M - Series B - May 2021
Coave Therapeutics (2021, France)
$25.1M - Series B - Jul 2021
View all 17 Funding Rounds on Tracxn Platform
Retinal Disorders Drugs
24
32
Back to index
Ophthalmology (Zeiss)
(# Cos: 1011 | $12.0B)
Drugs (Gyroscope)
(# Cos: 340 | $7.0B)
Retinal Disorders (CureVac)
(# Cos: 72 | $2.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$433M (▼51.4%)
17(▲6.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$2.2B
49
8
72
11
CureVac
(2000, Germany, $975M)
Visus Therapeutics
(2019, United States, $56.0M)
Rezolute
(2012, United States)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

33. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Kallyope (2014, United States)
$236M - Series D - Feb 2022
Verge Genomics (2015, United States)
$98.0M - Series B - Dec 2021
Alchemab (2019, United Kingdom)
$82.7M - Series A - Apr 2021
Bluepha (2014, China)
$66.4M - Series B - Aug 2021
Clear Labs (2014, United States)
$60.0M - Series C - May 2021
Lifebit (2017, United Kingdom)
$60.0M - Series B - Sep 2021
Tavotek (2018, United States)
$35.0M - Series B - Nov 2021
View all 24 Funding Rounds on Tracxn Platform
Genomics Research Services
25
33
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9834 | $52.5B)
Research Services (Ginkgo Bioworks)
(# Cos: 4984 | $30.2B)
Genomics (Ancestry)
(# Cos: 823 | $2.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$423M (▲62.5%)
24(▼22.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
59
$2.9B
244
20
823
29
Ancestry
(1996, United States, $146M)
Personalis
(2011, United States, $87.3M)
Caribou Biosciences
(2011, United States, $157M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

34. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Decentralized Clinical Trial Management
26
34
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$418M (▲215%)
4(▲33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
-
$560M
4
-
8
3
Life Sciences Tech (Exscientia)
(# Cos: 5001 | $28.0B)
Research & Development (Illumina)
(# Cos: 4017 | $23.3B)
Clinical Trials (Medidata)
(# Cos: 977 | $4.0B)
Study Implementation (Unlearn)
(# Cos: 499 | $2.0B)
CTMS and EDC (Florence)
(# Cos: 459 | $1.5B)
CTMS (IXICO)
(# Cos: 278 | $1.0B)
Decentralized Clinical Trials
(Medable)
(# Cos: 8 | $560M)
Medable
(2012, United States, $521M)
Curebase
(2017, United States, $19.0M)
Hawthorne Effect
(2015, United States, $20.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Medable (2012, United States)
$304M - Series D - Oct 2021
$78.0M - Series C - Apr 2021
Hawthorne Eff.. (2015, United States)
$20.0M - Series A - Jun 2021
Curebase (2017, United States)
$16.4M - Series A - May 2021

35. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
SHINE Medical.. (2010, United States)
$150M - Series C - Jun 2021
ITM (2004, Germany)
$36.4M - Series D - Mar 2022
$28.0M - Series D - Feb 2022
$30.5M - Series D - Jun 2021
$109M - Series D - Apr 2021
APRINOIA (2015, Taiwan)
$40.0M - Series C - Dec 2021
ImaginAb (2007, United States)
$12.8M - Series C - Jun 2021
View all 9 Funding Rounds on Tracxn Platform
Radioisotopes for Imaging
27
35
Back to index
Imaging Diagnostics (Butterfly Network)
(# Cos: 692 | $6.4B)
Accessories (Acusphere)
(# Cos: 130 | $1.7B)
Radioisotopes (Advanced Accelerator
Applications)
(# Cos: 80 | $1.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$411M (▲250%)
9(▲80%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
12
$1.6B
52
11
80
5
Advanced Accelerator A..
(2002, France, $56.1M)
Acusphere
(1993, United States, $35.0M)
TauRx
(2002, Singapore, $315M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

36. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
DNA Liquid Biopsy Diagnostics
28
36
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$407M (▼65.2%)
10(▼37.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$4.6B
62
6
97
11
Genomics (23andMe)
(# Cos: 7760 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4220 | $52.8B)
Clinical Genomics (Alnylam)
(# Cos: 2273 | $41.3B)
Diagnostics (Invitae)
(# Cos: 1643 | $27.5B)
Sequencing-based (Adaptive
Biotechnologies)
(# Cos: 1340 | $25.5B)
Liquid Biopsy (GRAIL)
(# Cos: 254 | $5.9B)
DNA (Guardant Health)
(# Cos: 97 | $4.6B)
Guardant Health
(2012, United States, $558M)
GRAIL
(2016, United States, $2.0B)
Scipher Medicine
(2014, United States, $227M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Scipher Medic.. (2014, United States)
$110M - Series D - Feb 2022
C2i Genomics (2019, United States)
$100M - Series B - Apr 2021
Nucleix (2008, Israel)
$22.0M - Series C - Jan 2022
Gene Solutions (2018, Vietnam)
$15.0M - Series B - Oct 2021
Foresight Dia.. (2020, United States)
$12.5M - Series A - Jun 2021
Saga Diagnostics (2016, Sweden)
$12.5M - Series A - Jun 2021
View all 10 Funding Rounds on Tracxn Platform

37. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
COVID-19 Drugs
29
37
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$404M (▼12.5%)
8(▼50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$1.2B
45
9
85
11
Infectious Diseases (Serum Institute of India)
(# Cos: 2003 | $28.5B)
Drugs (Adaptive Biotechnologies)
(# Cos: 1089 | $22.9B)
Viral (Moderna)
(# Cos: 500 | $12.6B)
COVID-19 (Adagio)
(# Cos: 85 | $1.2B)
Adagio
(2020, United States, $466M)
GigaGen
(2011, United States, $36.1M)
NantKwest
(2002, United States, $147M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Adagio (2020, United States)
$336M - Series C - Apr 2021
Apogenix (2005, Germany)
$29.4M - Series B - Dec 2021
Ethris (2009, Germany)
$26.3M - Series B - Feb 2022
Ashvattha The.. (2019, United States)
$7.7M - Series A - Apr 2021
RocketVax (2020, Switzerland)
$4.4M - Seed - Aug 2021
Touchlight (2008, United Kingdom)
Undisclosed - Series B - Sep 2021
Aerium Therap.. (2022, United States)
Undisclosed - Series A - Mar 2022
View all 8 Funding Rounds on Tracxn Platform

38. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
RNA Interference Platforms
30
38
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$367M (▼52.2%)
5(▼16.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
5
$1.9B
37
8
56
7
Genomics (MyHeritage)
(# Cos: 7760 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1695 | $17.2B)
Technology Platforms (Twist Bioscience)
(# Cos: 365 | $8.1B)
RNA interference (CureVac)
(# Cos: 56 | $1.9B)
CureVac
(2000, Germany, $975M)
Dicerna Pharmaceuticals
(2007, United States, $107M)
Expansion Therapeutics
(2016, United States, $140M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
Expansion The.. (2016, United States)
$80.0M - Series B - Sep 2021
Cardior Pharmaceuti.. (2016, Germany)
$75.2M - Series B - Aug 2021
Envisagenics (2013, United States)
$19.2M - Series A - Sep 2021
Apic Bio (2017, United States)
$4.5M - Series B - Mar 2022

39. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Delivery Platforms
31
39
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$360M (▲21.4%)
9(▼18.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
14
$2.1B
77
8
113
8
Genomics (MyHeritage)
(# Cos: 7760 | $82.8B)
Enabling Technologies (Illumina)
(# Cos: 1695 | $17.2B)
Technology Platforms (Twist Bioscience)
(# Cos: 365 | $8.1B)
Gene Delivery (Synthego)
(# Cos: 113 | $2.1B)
Synthego
(2012, United States, $460M)
LogicBio
(2013, United States, $50.0M)
Candel Therapeutics
(2018, United States, $65.2M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Synthego (2012, United States)
$200M - Series E - Feb 2022
Cambridge Ep.. (2012, United Kingdom)
$88.0M - Series D - Nov 2021
Genedit (2016, United States)
$26.0M - Series A - Sep 2021
Mekonos (2016, United States)
$25.0M - Series A - Nov 2021
Bendao Gene Technology (2018, China)
$9.2M - Series A - Apr 2021
Flash Therapeutics (2018, France)
$4.7M - Series A - Jul 2021
ViAqua Therapeutics (2014, Israel)
$4.3M - Series A - Jun 2021
View all 9 Funding Rounds on Tracxn Platform

40. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Drug Resistant Infections
32
40
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$343M (▼24.7%)
14(▼12.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
24
$3.8B
160
24
211
23
Infectious Diseases (Adaptive Biotechnologies)
(# Cos: 2003 | $28.5B)
Drugs (Moderna)
(# Cos: 1089 | $22.9B)
Bacterial (Locus Biosciences)
(# Cos: 332 | $5.3B)
Drug Resistant Infections (Paratek
Pharma)
(# Cos: 211 | $3.8B)
Paratek Pharma
(1996, United States, $96.5M)
Locus Biosciences
(2015, United States, $32.3M)
Bioversys
(2008, Switzerland, $28.4M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Vedanta Biosc.. (2010, United States)
$68.0M - Series D - Jul 2021
Adaptive Phag.. (2016, United States)
$20.0M - Series B - Apr 2022
$61.0M - Series B - May 2021
TenNor Therapeutics (2013, China)
$41.5M - Series D - Mar 2022
Micreos (2005, Netherlands)
$37.3M - Series D - Sep 2021
VenatoRx (2010, United States)
$34.0M - Series C - Apr 2022
Centauri The.. (2014, United Kingdom)
$32.5M - Series A - Feb 2022
View all 14 Funding Rounds on Tracxn Platform

41. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Chemoproteomics Software
33
41
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$341M (▲409%)
7(▲600%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
-
$408M
8
-
13
4
Life Sciences Tech (Illumina)
(# Cos: 5001 | $28.0B)
Research & Development (Medidata)
(# Cos: 4017 | $23.3B)
Drug Discovery (Exscientia)
(# Cos: 1205 | $12.5B)
Proteomics (Vividion Therapeutics)
(# Cos: 122 | $1.8B)
Chemoproteomics (Frontier Medicines)
(# Cos: 13 | $408M)
Frontier Medicines
(2018, United States, $156M)
Seismic
(2019, United States, $101M)
Interline Therapeutics
(2020, United States, $92.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Seismic (2019, United States)
$101M - Series A - Feb 2022
Interline The.. (2020, United States)
$92.0M - Series C - May 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
Gandeeva (2017, Canada)
$40.0M - Series A - Jan 2022
AI Proteins (2021, United States)
$11.3M - Series B - Jan 2022
Protai (2021, Israel)
$8.0M - Seed - Jan 2022
Abterra Biosc.. (2009, United States)
$200K - Seed - May 2021

42. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Life Science R&D Workflow
Management Software
34
42
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$335M (▲254%)
7(▲75%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$550M
16
-
51
4
Life Sciences Tech (Illumina)
(# Cos: 5001 | $28.0B)
Research & Development (Medidata)
(# Cos: 4017 | $23.3B)
Drug Informatics (BenevolentAI)
(# Cos: 792 | $4.5B)
R&D Workflow Management
(Benchling)
(# Cos: 51 | $550M)
Benchling
(2012, United States, $412M)
Standigm
(2015, South Korea, $68.0M)
Curoverse
(2010, United States, $1.7M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Benchling (2012, United States)
$100M - Series F - Nov 2021
$200M - Series E - Apr 2021
Code Ocean (2014, United States)
$15.0M - Series A - May 2021
Intelligencia (2018, United States)
$13.8M - Series A - Aug 2021
Standigm (2015, South Korea)
$10.0M - Series C - Jul 2021
Catalytic DS (2010, United States)
$5.8M - Series A - Jun 2021
Seqera Labs (2018, Spain)
$5.5M - Seed - Sep 2021

43. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Intravenous Drug Delivery Systems
35
43
Back to index
Drug Delivery (Impel NeuroPharma)
(# Cos: 871 | $8.0B)
Intravenous (Insulet)
(# Cos: 78 | $1.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$323M (▲1548%)
5(▼44.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
9
$1.2B
48
13
78
7
Insulet
(2000, United States, $120M)
Xeris Pharma
(2005, United States, $155M)
Sixfold Bioscience
(2017, United Kingdom, $10.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Enable Inject.. (2010, United States)
$215M - Series C - Jan 2022
Shasqi (2015, United States)
$50.0M - Series B - Nov 2021
Credence MedS.. (2011, United States)
$39.9M - Series D - Sep 2021
PharmaJet (2005, United States)
$15.4M - Series B - Apr 2021
Sixfold Bios.. (2017, United Kingdom)
$2.2M - Seed - Dec 2021

44. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
ABclonal Biot.. (2006, United States)
$188M - Series D - Dec 2021
PrognomiQ (2020, United States)
$46.0M - Series C - Mar 2022
Abrev Biotechnology (2018, China)
$40.0M - Series A - Nov 2021
List Biologic.. (1978, United States)
$17.4M - Series A - Mar 2022
$31.0M - Series A - Dec 2021
Debut (2019, United States)
$22.6M - Series A - Aug 2021
ITBMed (2016, Sweden)
$20.0M - Series A - Dec 2021
View all 20 Funding Rounds on Tracxn Platform
Proteomic Research Reagents and KIts
36
44
Back to index
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9834 | $52.5B)
Research Reagents and Kits (Adaptive
Biotechnologies)
(# Cos: 1944 | $5.9B)
Proteomics (AbSci)
(# Cos: 599 | $1.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$313M (▲231%)
20(▲66.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
57
$1.1B
154
14
599
10
AbSci
(2011, United States, $223M)
GenScript
(2002, United States, $15.0M)
PrognomiQ
(2020, United States, $101M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

45. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cardiac Diagnostic Devices
37
45
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$304M (▲365%)
14( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
18
$1.5B
135
11
301
19
Cardiac and Vascular Disorders (Moderna)
(# Cos: 2608 | $31.6B)
Medical Devices (Withings)
(# Cos: 2098 | $19.9B)
Screening Devices (Acutus Medical)
(# Cos: 421 | $2.8B)
Cardiac Diagnostic (Eko)
(# Cos: 301 | $1.5B)
Eko
(2013, United States, $125M)
AliveCor
(2011, United States, $114M)
Ultromics
(2017, United Kingdom, $60.6M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Imperative Care (2015, United States)
$260M - Series D - Jul 2021
Ultromics (2017, United Kingdom)
$33.0M - Series B - Aug 2021
Eko (2013, United States)
$30.0M - Series C - Mar 2022
Bertis (2014, South Korea)
$13.5M - Series B - Jun 2021
evismo (2018, Switzerland)
$1.1M - Seed - Sep 2021
MiRTLE Medical (2012, United States)
$525K - Seed - Dec 2021
Lyfas (2017, India)
$102K - Angel - Aug 2021
View all 14 Funding Rounds on Tracxn Platform

46. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Inari (2016, United States)
$208M - Series D - May 2021
Equinom (2012, Israel)
$20.0M - Series C - Jun 2021
Biome Makers (2015, United States)
$15.0M - Series B - Aug 2021
Meiogenix (2010, France)
$13.0M - Series A - Dec 2021
Phylos Biosci.. (2014, United States)
$7.6M - Series C - Feb 2022
$12.2M - Series C - Apr 2021
Plastomics (2016, United States)
$7.1M - Series A - Nov 2021
View all 13 Funding Rounds on Tracxn Platform
Agrigenomics
38
46
Back to index
Genomics (23andMe)
(# Cos: 7760 | $82.8B)
Applied Genomics (MyHeritage)
(# Cos: 4220 | $52.8B)
Agrigenomics (Limagrain)
(# Cos: 301 | $2.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$300M (▼42.4%)
13(▼43.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
35
$2.6B
139
18
301
23
Limagrain
(1965, France, $200M)
Arcadia Biosciences
(2002, United States, $101M)
Cibus
(2001, United States, $181M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

47. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ceptur Therap.. (2021, United States)
$75.0M - Series A - Jan 2022
Alebund (2018, China)
$54.5M - Series B - Sep 2021
$60.0M - Series B - May 2021
Hangzhou Andao Pharma.. (2014,
China)
$50.0M - Series B - Dec 2021
Renibus Thera.. (2013, United States)
$34.6M - Series A - Feb 2022
Wuhan Metwell Biotech.. (2015, China)
$15.5M - Series A - Sep 2021
Oncorena (2011, Sweden)
$7.2M - Series A - Dec 2021
View all 9 Funding Rounds on Tracxn Platform
Renal Disorders Drugs
39
47
Back to index
Metabolic Diseases (Nimbus Therapeutics)
(# Cos: 428 | $10.7B)
Drugs (Sigilon)
(# Cos: 299 | $9.3B)
Renal Disorders (Akebia Therapeutics)
(# Cos: 79 | $2.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$300M (▲125%)
9(▼10%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$2.2B
65
14
79
11
Akebia Therapeutics
(2007, United States, $91.0M)
Resverlogix
(2001, Canada, $129M)
Allena
(2011, United States, $96.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

48. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ultrasound Imaging Devices
40
48
Back to index
Imaging Diagnostics (INSIGHTEC)
(# Cos: 692 | $6.4B)
Ultrasound (Butterfly Network)
(# Cos: 119 | $1.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$300M (▲96.7%)
6(▼14.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$1.8B
51
6
119
9
Butterfly Network
(2011, United States, $350M)
INSIGHTEC
(1999, Israel, $487M)
Exo
(2015, United States, $346M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Exo (2015, United States)
$220M - Series C - Jul 2021
EchoNous (2015, United States)
$60.0M - Series C - Jun 2021
Clarius (2014, Canada)
$15.6M - Series B - Mar 2022
Pulsify Medical (2019, Belgium)
$4.5M - Series A - May 2021
Focus & Fusion (2014, China)
Undisclosed - Series B - May 2021
Shenzhen Aosheng .. (2016, Singapore)
Undisclosed - Series A - Apr 2022

49. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Wound Healing Drugs
41
49
Back to index
Wound Care (ConvaTec Group)
(# Cos: 544 | $2.0B)
Drugs (Ilya Pharma)
(# Cos: 189 | $1.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$299M (▲83%)
9(▼18.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$1.2B
126
22
189
11
Ilya Pharma
(2016, Sweden, $4.0M)
Adocia
(2005, France, $26.0M)
Derma Sciences
(1984, United States, $18.2M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Endeavor Biom.. (2018, United States)
$101M - Series B - Feb 2022
QBiotics (2000, Australia)
$64.4M - Series C - Jun 2021
CytoKi Pharma (2019, Denmark)
$45.0M - Series A - May 2021
TargED (2020, Netherlands)
$44.2M - Series A - Feb 2022
FirstString R.. (2006, United States)
$26.7M - Series B - Jun 2021
Stemson Thera.. (2019, United States)
$15.0M - Series A - Jul 2021
Biotherapy S.. (2013, United Kingdom)
$2.1M - Series A - Jul 2021
View all 9 Funding Rounds on Tracxn Platform

50. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
DNAnexus (2009, United States)
$200M - Series H - Mar 2022
Immunitas The.. (2019, United States)
$58.0M - Series B - Aug 2021
Seven Bridges.. (2009, United States)
$15.0M - Series C - Apr 2021
Geneyx (2018, Israel)
$6.5M - Seed - Nov 2021
My Intelligent Machi.. (2016, Canada)
$5.0M - Seed - Apr 2021
AarogyaAI (2019, India)
$700K - Seed - Jan 2022
Scailyte (2017, Switzerland)
Undisclosed - Series A - Jan 2022
View all 8 Funding Rounds on Tracxn Platform
Genome Sequence Analysis Software
42
50
Back to index
Genomics (MyHeritage)
(# Cos: 7760 | $82.8B)
Genome Informatics (Benchling)
(# Cos: 769 | $5.6B)
Sequence Analysis (DNAnexus)
(# Cos: 265 | $1.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$285M (▲45.9%)
8(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
25
$1.2B
90
2
265
11
DNAnexus
(2009, United States, $473M)
Scailyte
(2017, Switzerland, $6.0M)
Immunitas Therapeutics
(2019, United States, $97.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

51. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Healthcare Data Analysis for Drug
Discovery
43
51
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$277M (▲798%)
6(▼14.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$596M
16
-
50
4
Life Sciences Tech (Illumina)
(# Cos: 5001 | $28.0B)
Research & Development (Medidata)
(# Cos: 4017 | $23.3B)
Drug Informatics (Benchling)
(# Cos: 792 | $4.5B)
Healthcare Data Analysis
(Flywheel)
(# Cos: 50 | $596M)
Flywheel
(2015, United States, $51.7M)
Verana Health
(2011, United States, $288M)
Geneyx
(2018, Israel, $6.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Verana Health (2011, United States)
$150M - Series E - Jan 2022
Truveta (2020, United States)
$95.0M - Series A - Jul 2021
Flywheel (2015, United States)
Undisclosed - Series C - Nov 2021
$22.0M - Series C - Sep 2021
Geneyx (2018, Israel)
$6.5M - Seed - Nov 2021
LunaDNA (2017, United States)
$3.8M - Series A - May 2021

52. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
At-Home Preventive Genetic Test Kits
44
52
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$274M (▼38.1%)
8(▼27.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$1.5B
55
2
239
8
Genomics (Ginkgo Bioworks)
(# Cos: 7760 | $82.8B)
Applied Genomics (23andMe)
(# Cos: 4220 | $52.8B)
Consumer Genomics (MyHeritage)
(# Cos: 857 | $3.3B)
Proactive Healthcare (Everlywell)
(# Cos: 239 | $1.5B)
Everlywell
(2015, United States, $330M)
Color
(2013, United States, $491M)
Viome
(2016, United States, $125M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Variant Bio (2018, United States)
$105M - Series B - Nov 2021
Color (2013, United States)
$100M - Series E - Nov 2021
Viome (2016, United States)
$54.0M - Series B - Nov 2021
Recuro Health (2021, United States)
Undisclosed - Series A - Dec 2021
$15.0M - Series A - Aug 2021
Dive Health (2019, United States)
$125K - Seed - Sep 2021
Arcensus (2020, United States)
Undisclosed - Seed - Feb 2022
View all 8 Funding Rounds on Tracxn Platform

53. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Hemodialyzers
45
53
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$269M (▲1389%)
2(▼50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
6
$905M
18
2
20
3
Nephrology (Akebia Therapeutics)
(# Cos: 201 | $3.9B)
Medical Devices (MediBeacon)
(# Cos: 89 | $1.2B)
Therapeutic Devices (Nephros)
(# Cos: 72 | $1.1B)
Chronic Kidney Diseases (Fresenius)
(# Cos: 64 | $1.0B)
Renal Replacement (Hemotune)
(# Cos: 63 | $1.0B)
Dialysis (Quanta)
(# Cos: 49 | $1.0B)
Hemodialysis (Outset Medical)
(# Cos: 20 | $905M)
Outset Medical
(2003, United States, $458M)
Quanta
(2008, United Kingdom, $363M)
Hemotune
(2017, Switzerland, $10.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Quanta (2008, United Kingdom)
$245M - Series D - Jun 2021
Diality (2013, United States)
$24.0M - Series B - Mar 2022

54. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Esco Lifesciences (1978, Singapore)
$200M - Series A - May 2021
Sphere Fluid.. (2010, United Kingdom)
$40.0M - Series C - Oct 2021
Mozhuo Biotechnology (2016, China)
$23.1M - Series A - Aug 2021
VitalFluid (2014, Netherlands)
$2.3M - Seed - Jan 2022
ThunderBio Innovation (2018, China)
Undisclosed - Seed - Aug 2021
Undisclosed - Series A - Aug 2021
Baicare (2016, China)
Undisclosed - Series C - Oct 2021
View all 8 Funding Rounds on Tracxn Platform
Life Sciences Research Instruments
46
54
Back to index
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9834 | $52.5B)
Instruments (Illumina)
(# Cos: 2050 | $12.7B)
Diversified (Bruker)
(# Cos: 373 | $640M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$265M ( -- )
8( -- )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
43
$640M
81
15
373
3
Bruker
(1960, United States)
10X Genomics
(2012, United States, $243M)
Esco Lifesciences
(1978, Singapore, $200M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

55. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Dermavant (2016, United States)
$160M - Series D - Jun 2021
CytoKi Pharma (2019, Denmark)
$45.0M - Series A - May 2021
$19.2K - Seed - Apr 2021
Pyramid Bio (2015, United States)
$33.5M - Series C - Oct 2021
Cytovation (2001, Norway)
$20.0M - Series A - Jan 2022
Aesthetic Medicines
47
55
Back to index
Dermatology (Castle Biosciences)
(# Cos: 885 | $7.5B)
Drugs (Incyte)
(# Cos: 338 | $6.0B)
Aesthetics (Revance Therapeutics)
(# Cos: 244 | $3.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$259M (▲202%)
5(▼50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
44
$3.9B
175
30
244
14
Revance Therapeutics
(2002, United States, $191M)
Sienna Biopharmaceutic..
(2016, United States, $133M)
Vyome Therapeutics
(2010, United States, $62.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

56. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Congestive Heart Failure Treatment
Devices
48
56
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$256M (▲20.5%)
15( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
16
$2.5B
90
7
107
21
Cardiac and Vascular Disorders (Moderna)
(# Cos: 2608 | $31.6B)
Medical Devices (Withings)
(# Cos: 2098 | $19.9B)
Therapeutic Devices (Inari Medical)
(# Cos: 1011 | $14.9B)
Congestive Heart Failure (Sequena
Medical)
(# Cos: 107 | $2.5B)
Sequena Medical
(2006, Switzerland, $35.5M)
Abiomed
(1981, United States)
Avive
(2017, United States, $42.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Ancora Heart (2001, United States)
$80.0M - Series D - Jul 2021
Avive (2017, United States)
$35.9M - Series A - Mar 2022
AdjuCor (2008, Germany)
$35.1M - Series B - Jun 2021
Impulse Dynamics (1996, Germany)
$31.0M - Series D - Feb 2022
CoRISMA (2018, United States)
$27.0M - Series A - Aug 2021
Bivacor (2008, United States)
$19.0M - Series B - May 2021
FineHeart (2010, France)
$18.3M - Series B - Jun 2021
View all 15 Funding Rounds on Tracxn Platform

57. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
HilleVax (2021, United States)
$135M - Series D - Sep 2021
Pulmocide (2013, United Kingdom)
$3.5M - Series C - Dec 2021
$92.0M - Series C - May 2021
Cargene Therapeut.. (2020, Singapore)
$19.2M - Seed - Dec 2021
Pulmotect (2007, United States)
$2.2M - Series A - Feb 2022
Peroxitech (2017, United States)
Undisclosed - Seed - May 2021
Lung Infection Drugs
49
57
Back to index
Pulmonology (Mallinckrodt Pharmaceuticals)
(# Cos: 657 | $7.9B)
Drugs (ASLAN Pharmaceuticals)
(# Cos: 194 | $4.7B)
Lung Infections (Icosavax)
(# Cos: 22 | $641M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$252M (▲35%)
6(▼14.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$641M
16
3
22
4
Icosavax
(2017, United States, $152M)
ReViral
(2011, United Kingdom, $121M)
HilleVax
(2021, United States, $135M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

58. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Drug Development Immunoassays
50
58
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$251M (▲42.6%)
11(▲57.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
15
$708M
44
5
111
11
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9834 | $52.5B)
Research Assays (Phoremost)
(# Cos: 594 | $3.2B)
Drug Discovery (Abingdon Health)
(# Cos: 393 | $2.8B)
Immunoassays (AbCellera)
(# Cos: 111 | $708M)
AbCellera
(2012, Canada, $115M)
Abingdon Health
(2008, United Kingdom, $24.1M)
Mitra Biotech
(2010, United States, $84.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Virtue Diagnostics (2019, China)
$100M - Series B - Jan 2022
Alamar Biosci.. (2018, United States)
$80.0M - Series B - Sep 2021
Nomic Bio (2018, Canada)
$17.0M - Series A - Dec 2021
ET Healthcare (2008, China)
$15.5M - Series D - May 2021
Eclipse Bio (2017, United States)
$14.0M - Series A - Mar 2022
Amberstone Bi.. (2016, United States)
$12.0M - Series A - Jan 2022
Accellix (2013, United States)
$10.0M - Series D - Dec 2021
View all 11 Funding Rounds on Tracxn Platform

59. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Recent funding rounds
Investment Trends
Most Active Investors
Top Funded Business Models
Explore more on Tracxn
All Tech Companies
US Tech Companies
Online Travel Companies
Companies using AI in Healthcare
Companies founded by Stanford GSB Alumni
Soonicorn club in Fintech
Analyst Picks in Israel Tech
Key News in FinTech
Events in Bay Area
Angel Investors in United States
Bluebox
Companies Investment Activity
Miscellaneous
Company Detail Page of DoorDash
Competitors of Freshworks
Cap Table for TransferWise
Financials for Ola
Employee Count for Revolut
Company Due Diligence Exits
Public Companies
Acquired Companies
Most Active Acquirers
Reports
Delhivery - Company Report
Novel Foods - Business Model Report
HRTech - Feed Report
FinTech - Top Business Models Report
US Tech - Top Business Models Report
US Tech - Monthly Report
59

60. Life Sciences - Top Business Models Report Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Explore other Reports on Tracxn
HRTech
InsurTech
Food Tech
Novel Foods
Blockchain Network
P2P Remittance
Business Model Reports
FinTech Europe
Consumer Digital SEA
HiTech US
Feed Geo Reports
Company Reports
Monthly Unicorn Report
Unicorn Reports
Transferwise
Coursera
BigBasket
Feed Reports Top Business Models in PA
FinTech
Enterprise Applications
Artificial Intelligence
Geo Monthly Reports
US Tech
Europe Tech
China Tech
Top Business Models in Geo
India Tech
Israel Tech
UK & Ireland Tech
60

61. Copyright © 2022, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Thank You
61
Any and all information either accessed from the website www.tracxn.com or having otherwise originated from Tracxn Technologies Limited including but not limited to the information
contained herein ("Data") is the sole property of Tracxn Technologies Limited (hereinafter "Tracxn"). You shall not recirculate, distribute, transmit, publish, or sell the Data or any portion
thereof in any form or by any means, either for commercial or non-commercial use, or permit any third party to use or distribute the Data or any portion thereof; to any other party, except
with the prior written consent of Tracxn. You may however incorporate insubstantial portions, extracts, abstracts or summaries from the Data into analysis, presentations or tools for your
customers or for your internal use, so long as Tracxn is clearly and visibly identified as the source of information.
For further information please refer to our Terms of Use at www.tracxn.com